Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotinylated gene therapy vectors.

Michael A Barry1, Samuel K Campos, Debadyuti Ghosh

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Rice University, One Baylor Plaza, N1020, Houston, TX 77030, USA. mab@bcm.tmc.edu

Expert Opinion on Biological Therapy
|August 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicatheter Comparison of Very High-Power Short-Duration Radiofrequency Ablation Lesions.

Journal of cardiovascular electrophysiology·2026
Same author

Immune shielding of viral vectors via capsid engineering with genetically encoded zwitterionic peptides.

Molecular therapy. Advances·2026
Same author

Esophageal heating characteristics of very high-power short duration radiofrequency ablation in a myocardial phantom model.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Transvenous microwave aorticorenal ganglion ablation improves renal denervation outcomes.

Journal of hypertension·2026
Same author

Mechanisms that create a sequence of feeding-related behaviors in the mollusk <i>Aplysia</i>.

Journal of neurophysiology·2026
Same author

Comparison of Immune Cell Transfection by Different Vaccine Vectors After Intradermal Injection.

Vaccines·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
Same journal

Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

Expert opinion on biological therapy·2026
See all related articles

The avidin-biotin system enhances gene therapy vectors using chemical or metabolic biotinylation. Metabolic biotinylation offers advantages for purifying biotinylated viruses, vectors, and vaccines.

Area of Science:

  • Biomedicine
  • Molecular Biology
  • Gene Therapy

Background:

  • The avidin-biotin system is crucial for various biomedical applications, including labeling and imaging.
  • Gene therapy vectors are increasingly utilizing this system for enhanced targeting and delivery.
  • Two primary biotinylation methods, chemical and metabolic, are employed.

Purpose of the Study:

  • To review the adaptation of the avidin-biotin system for gene therapy vectors.
  • To compare chemical and metabolic biotinylation strategies.
  • To highlight the potential of these technologies in cell targeting and ligand screening.

Main Methods:

  • Chemical biotinylation involves random covalent attachment of biotin to proteins.
  • Metabolic biotinylation genetically engineers proteins with a biotin acceptor peptide (BAP) for cellular biotin ligase activity.

Related Experiment Videos

  • Both methods are evaluated for in vitro and in vivo applications.

    • Main Results:

    • Both chemical and metabolic biotinylation show promise for cell targeting and ligand screening.
    • Metabolic biotinylation enables the production of pre-biotinylated viruses, vectors, and vaccines.
    • Pre-biotinylated products can be purified using affinity chromatography on monomeric avidin columns.

    Conclusions:

    • Avidin-biotin technology offers versatile tools for gene therapy vector development.
    • Metabolic biotinylation provides a streamlined purification process for modified vectors and vaccines.
    • These advancements hold significant potential for improving the efficacy and application of gene therapies.